Singapore markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
14.07+0.05 (+0.36%)
At close: 4:00PM EDT
14.10 +0.03 (+0.21%)
After hours: 07:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Total revenue
3,345,565,000
3,197,812,000
3,291,188,000
2,097,224,000
1,770,531,000
Cost of revenue
997,494,000
994,308,000
1,089,764,000
659,690,000
495,921,000
Gross profit
2,348,071,000
2,203,504,000
2,201,424,000
1,437,534,000
1,274,610,000
Operating expenses
Research development
471,492,000
455,833,000
492,381,000
368,298,000
325,441,000
Selling general and administrative
893,132,000
875,663,000
964,737,000
717,599,000
628,106,000
Total operating expenses
1,928,493,000
1,865,193,000
1,926,716,000
1,277,169,000
1,032,821,000
Operating income or loss
419,578,000
338,311,000
274,708,000
160,365,000
241,789,000
Interest expense
155,028,000
130,806,000
149,010,000
48,158,000
31,928,000
Total other income/expenses net
175,172,000
165,770,000
-188,813,000
-4,510,000
-32,199,000
Income before tax
458,922,000
366,235,000
-60,754,000
94,896,000
217,205,000
Income tax expense
27,544,000
-9,936,000
-105,044,000
-14,118,000
30,497,000
Income from continuing operations
431,378,000
376,171,000
44,290,000
109,014,000
186,708,000
Net income
431,178,000
376,005,000
44,241,000
109,126,000
186,886,000
Net income available to common shareholders
431,178,000
376,005,000
44,241,000
109,126,000
186,886,000
Basic EPS
-
120.36
14.21
56.75
119.67
Diluted EPS
-
119.48
14.12
56.43
118.78
Basic average shares
-
3,124,012
3,114,408
1,922,954
1,561,613
Diluted average shares
-
3,147,074
3,132,408
1,933,794
1,573,379
EBITDA
-
1,056,712,000
671,905,000
415,500,000
431,260,000